Comparing Metabolic Profiles of Rectal Cancer and Xenografts
Author Information
Author(s): Seierstad Therese, Røe Kathrine, Sitter Beathe, Halgunset Jostein, Flatmark Kjersti, Ree Anne H, Olsen Dag Rune, Gribbestad Ingrid S, Bathen Tone F
Primary Institution: Rikshospitalet-Radiumhospitalet Medical Center
Hypothesis
This study aims to elucidate metabolic differences between human rectal cancer biopsies and colorectal xenografts using high-resolution magnetic resonance spectroscopy.
Conclusion
The HT29 xenografts exhibited a metabolic profile most similar to human rectal cancer tissue, but significant differences in necrotic fractions were observed.
Supporting Evidence
- 27 metabolites were identified and assigned in the HR MAS MR spectra.
- PCA revealed separate clusters of the different xenografts and rectal biopsies.
- HT29 xenografts showed the metabolic profile most similar to human rectal cancer tissue.
Takeaway
Researchers looked at cancer samples to see how they differ from lab-grown cancer cells, finding that one type of lab cell is very similar to real cancer tissue.
Methodology
High-resolution magic angle spinning magnetic resonance spectroscopy was used to analyze tissue samples from xenografts and rectal biopsies.
Potential Biases
Potential bias due to the differences in necrotic fractions between human samples and xenografts.
Limitations
The study's findings may be limited by the high necrotic fractions in the xenografts, which could affect the metabolic profiles observed.
Participant Demographics
10 patients (7 men and 3 women) with a median age of 58 years (range; 43–73) provided rectal cancer biopsies.
Statistical Information
P-Value
p < 0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website